PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE DMAC Holdings History
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's DiaMedica Therapeutics Inc Holding Summary
As of 2025-03-31, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT V held 600,000.00 shares of DiaMedica Therapeutics Inc(DMAC), totaling $2.27 Mil. This investment constitutes 5.33% of their stock portfolio, and PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT V now holds 1.4% of the outstanding DiaMedica Therapeutics Inc(DMAC) stock.
The initial trade took place in 2023Q2. And since then PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE has made 5 purchases of DMAC, at an average price of $3.18, for a total of 617,386.00 shares. In addition, there have been 1 sales at an average price of $2.74 for 17,386.00 shares. Based on historical transaction data and DMAC's current price of $4.18, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's estimated gain on his DMAC holdings is $593,559.72, reflecting a 30.25% gain to date.
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE DMAC ($4.18) Holding Chart
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE DMAC ($4.18) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
